Transcriptional Co-activator PGC-1 Alpha Drives the Formation of Slow-twitch Muscle Fibres
Authors
Affiliations
The biochemical basis for the regulation of fibre-type determination in skeletal muscle is not well understood. In addition to the expression of particular myofibrillar proteins, type I (slow-twitch) fibres are much higher in mitochondrial content and are more dependent on oxidative metabolism than type II (fast-twitch) fibres. We have previously identified a transcriptional co-activator, peroxisome-proliferator-activated receptor-gamma co-activator-1 (PGC-1 alpha), which is expressed in several tissues including brown fat and skeletal muscle, and that activates mitochondrial biogenesis and oxidative metabolism. We show here that PGC-1 alpha is expressed preferentially in muscle enriched in type I fibres. When PGC-1 alpha is expressed at physiological levels in transgenic mice driven by a muscle creatine kinase (MCK) promoter, a fibre type conversion is observed: muscles normally rich in type II fibres are redder and activate genes of mitochondrial oxidative metabolism. Notably, putative type II muscles from PGC-1 alpha transgenic mice also express proteins characteristic of type I fibres, such as troponin I (slow) and myoglobin, and show a much greater resistance to electrically stimulated fatigue. Using fibre-type-specific promoters, we show in cultured muscle cells that PGC-1 alpha activates transcription in cooperation with Mef2 proteins and serves as a target for calcineurin signalling, which has been implicated in slow fibre gene expression. These data indicate that PGC-1 alpha is a principal factor regulating muscle fibre type determination.
Molecular breeding of pigs in the genome editing era.
Chen J, Wang J, Zhao H, Tan X, Yan S, Zhang H Genet Sel Evol. 2025; 57(1):12.
PMID: 40065264 PMC: 11892312. DOI: 10.1186/s12711-025-00961-7.
Castillo I, Argiles J, Rueda R, Ramirez M, Pedrosa J Rev Endocr Metab Disord. 2025; .
PMID: 40064750 DOI: 10.1007/s11154-025-09954-9.
Metabolic dysregulation contributes to the development of dysferlinopathy.
Furrer R, Dilbaz S, Steurer S, Santos G, Karrer-Cardel B, Ritz D Life Sci Alliance. 2025; 8(5).
PMID: 40021220 PMC: 11871293. DOI: 10.26508/lsa.202402991.
Parafati M, Thwin Z, Malany L, Coen P, Malany S bioRxiv. 2025; .
PMID: 39974935 PMC: 11838239. DOI: 10.1101/2025.01.26.634580.
Palzkill V, Tan J, Moparthy D, Tice A, Ferreira L, Ryan T JACC Basic Transl Sci. 2025; 10(1):88-103.
PMID: 39906594 PMC: 11788496. DOI: 10.1016/j.jacbts.2024.08.011.